Methylphenidate HCl 30 mg Slow Release Capsules (Gluten Free) are designed to treat conditions such as ADHD, Narcolepsy, Depression, and Bipolar Disorder. These capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance. Importantly, this formulation is gluten-free, catering to those with specific dietary requirements.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to offer Methylphenidate HCl 30 mg Slow Release Capsules (Gluten Free), a compounded formulation designed to provide a controlled and prolonged release of the active ingredient, methylphenidate HCl. This medication is primarily used in the treatment of ADHD, Narcolepsy, Attention Deficit Disorder, Depression, and Bipolar Disorder.
Methylphenidate HCl is a stimulant medication that works by increasing the levels of dopamine and norepinephrine in the brain. This action helps to improve focus, concentration, and alertness, while also reducing impulsivity and hyperactivity, which are common symptoms in the aforementioned conditions.
The unique formulation of our Methylphenidate HCl 30 mg Slow Release Capsules incorporates Methocel E4M, a type of controlled-release polymer. This technology ensures a gradual release of the medication over an extended period of time, offering sustained therapeutic effects. This slow release mechanism not only enhances the effectiveness of the medication but also reduces the risk of potential side effects. Furthermore, the reduced dosing frequency improves patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
Additionally, our Methylphenidate HCl 30 mg Slow Release Capsules are gluten-free, making them a suitable treatment option for patients with gluten sensitivities or celiac disease.
If you have any questions about our Methylphenidate HCl 30 mg Slow Release Capsules (Gluten Free) or any other compounded formulations we offer, please do not hesitate to contact us. Our team of compounding pharmacists is always ready to assist and provide the necessary information to help you make informed decisions about your health.
This compounded formulation of Methylphenidate HCl 30 mg Slow Release Capsules (Gluten Free) is specifically designed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Attention Deficit Disorder (ADD), Depression, and Bipolar Disorder. Methylphenidate, a central nervous system stimulant, functions by augmenting the quantity of certain natural substances in the brain that are essential for controlling behavior and attention.
It is crucial to understand that Methylphenidate should not be utilized to treat fatigue or to delay sleep in individuals who do not have a sleep disorder. Methylphenidate may interact with other medications, including monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, and other stimulants. Therefore, it is important to inform your healthcare provider about all other medications, vitamins, and herbs you are currently taking before initiating treatment with Methylphenidate.
Patients on this medication should be closely monitored for signs of increased blood pressure, heart rate, or changes in behavior. Additionally, signs of depression, suicidal thoughts, or unusual changes in behavior should be vigilantly observed. It is noteworthy that Methylphenidate may cause drowsiness or dizziness, and should be used with caution when driving or operating machinery. Patients should also be aware that Methylphenidate may cause stomach upset, loss of appetite, or weight loss.
If you have any queries regarding the use of Methylphenidate for the treatment of ADHD, Narcolepsy, Attention Deficit Disorder, Depression, or Bipolar Disorder, please do not hesitate to reach out for further information.
Methylphenidate HCl 30 mg Slow Release Capsules (Gluten Free) is a compounded formulation designed to treat a range of conditions including Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Attention Deficit Disorder (ADD), Depression, and Bipolar Disorder. This medication functions by elevating the levels of dopamine and norepinephrine in the brain, thereby enhancing focus, concentration, and alertness.
The unique feature of this formulation is its slow-release mechanism, achieved through the use of Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release formulation ensures a steady and prolonged release of the medication, allowing for more consistent symptom relief and reduced dosing frequency, which can lead to improved patient compliance.
Another significant aspect of this formulation is that it is gluten-free, making it an appropriate choice for individuals with gluten sensitivities or allergies. It is crucial to adhere to the instructions provided by your healthcare provider when taking this medication. It should be taken as prescribed and not more frequently than directed. Consistency is key, so taking this medication at the same time each day will ensure optimal symptom relief.
It is also important to avoid combining this medication with alcohol or other medications that may interact with it. If you have any questions or concerns about this formulation or its mechanism of action, please do not hesitate to reach out.
Methylphenidate HCl 30 mg Slow Release Capsules (Gluten Free) are meticulously formulated with Methocel E4M, a specialized controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism not only reduces the frequency of dosing but also enhances patient compliance, particularly for medications that necessitate a controlled and prolonged release profile.
While primarily used for attention deficit hyperactivity disorder (ADHD), these capsules can also be employed to manage other conditions such as obesity, fatigue, and sleep disorders. Off-label uses include treating cognitive deficits in patients with traumatic brain injury, stroke, and dementia. It has also shown efficacy in managing chronic pain and alleviating symptoms of opioid withdrawal.
As methylphenidate is a stimulant, it should be used judiciously in patients with a history of substance abuse. It is contraindicated in patients with a history of cardiovascular disease, glaucoma, or seizure disorders. Potential side effects such as insomnia, anxiety, and agitation necessitate careful monitoring of patients. For any queries or concerns regarding the use of this formulation, please do not hesitate to contact us.
Methylphenidate HCl 30 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer called Methocel E4M. This formulation is designed to gradually release the medication over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is used in the formulation to ensure that the medication is released gradually over an extended period of time. This offers sustained therapeutic effects and reduces the frequency of dosing.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
Yes, Methylphenidate HCl 30 mg Slow Release Capsules is a gluten-free medication. This makes it suitable for individuals with gluten intolerance or celiac disease.
The frequency of dosing for Methylphenidate HCl 30 mg Slow Release Capsules is typically less than that of regular medications due to its slow release formulation. However, the exact dosing schedule should be determined by your healthcare provider based on your specific needs and condition.
Methylphenidate HCl 30 mg Slow Release Capsules provides a sustained therapeutic effect over an extended period of time due to its slow release formulation. This means that the medication continues to work for a longer period compared to regular medications.
Methylphenidate HCl 30 mg Slow Release Capsules is a medication that should be taken under the supervision of a healthcare provider. It is not suitable for everyone and should only be taken if prescribed by a healthcare provider.
If you miss a dose of Methylphenidate HCl 30 mg Slow Release Capsules, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
No, Methylphenidate HCl 30 mg Slow Release Capsules should not be crushed or chewed. Doing so can release all of the medication at once, increasing the risk of side effects. The capsules should be swallowed whole.
If you experience any side effects from Methylphenidate HCl 30 mg Slow Release Capsules, contact your healthcare provider immediately. They can provide guidance on how to manage the side effects and determine whether the medication is right for you.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth